BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides

2017 ◽  
Vol 57 (11) ◽  
pp. 1460-1471 ◽  
Author(s):  
Kei Sakamoto ◽  
Shunji Matsuki ◽  
Kyoko Matsuguma ◽  
Tatsuya Yoshihara ◽  
Naoki Uchida ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Aβ Peptides ◽  
Bace1 Inhibitor ◽  
Japanese Subjects

scholarly journals Pharmacokinetic Comparison of Capsule and Tablet Formulations of Opicapone in Healthy Japanese Subjects: Phase 1 Study

2020 ◽  
Author(s):  
Masahiro Nomoto ◽  
Atsushi Takeda ◽  
Katsuaki Iwai ◽  
Akihisa Nishimura ◽  
Nobutaka Hattori
Keyword(s):  
Phase 1 ◽  
Phase 1 Study ◽  
Tablet Formulations ◽  
Japanese Subjects

scholarly journals A phase 1 study of single agent veliparib in Japanese subjects with advanced solid tumors

2016 ◽  
Vol 27 ◽  
pp. vi302
Author(s):  
K. Matsumoto ◽  
K. Tamura ◽  
H. Yoshida ◽  
T. Nishikawa ◽  
Y. Imai ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Single Agent ◽  
Advanced Solid Tumors ◽  
Phase 1 Study ◽  
Japanese Subjects

scholarly journals Effect of Opicapone Tablets on Levodopa and 3‐O‐Methyldopa Pharmacokinetics in Healthy Japanese Subjects: Phase 1 Study

2020 ◽  
Author(s):  
Masahiro Nomoto ◽  
Atsushi Takeda ◽  
Katsuaki Iwai ◽  
Akihisa Nishimura ◽  
Nobutaka Hattori
Keyword(s):  
Phase 1 ◽  
Phase 1 Study ◽  
Japanese Subjects
Sign in / Sign up

Export Citation Format

Share Document